LINKBANCORP, Inc. operates as bank holding company. The company is headquartered in Camp Hill, Pennsylvania and currently employs 296 full-time employees. The company went IPO on 2020-02-19. The firm's subsidiary bank, LINKBANK (the Bank), is a Pennsylvania state-chartered bank serving individuals, families, nonprofits and business clients throughout Pennsylvania, Maryland, Delaware and Virginia through 24 client solutions centers and www.linkbank.com. The company offers a full suite of deposit products and cash management services focused on the small business and nonprofit segments. Its principal lending activity has been the origination of commercial real estate loans, commercial business loans, and to a lesser extent, commercial real estate construction and land development loans, residential real estate loans, home equity loans, consumer loans and agriculture loans. Its commercial real estate and multi-family loans generally have amortization terms of 15 to 25 years and have adjustable interest rates. The company offers both fixed-rate and adjustable-rate construction and land loans, although most of these loans have fixed interest rates.
SAB Biotherapeutics Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
LINKBANCORP Inc 的收入按细分市场或地理位置如何划分?
SAB Biotherapeutics Inc 주요 수익원은 Immunotheraphies이며, 최신 수익 발표에서 수익은 2,238,991입니다. 지역별로는 United States이 SAB Biotherapeutics Inc의 주요 시장이며, 수익은 2,238,991입니다.